Melissa Copland
medical professionalFemale0.0Global Dominance: 0.00%
Melissa Copland is the clinical lead of medicines management at Pharmac, New Zealand's pharmaceutical management agency. She recently confirmed the funding of desogestrel, branded as Cerazette, which will be available from April 1 for individuals needing treatment for endometriosis. This decision is expected to benefit over 43,000 New Zealanders and aims to improve access to effective treatment for those suffering from the debilitating symptoms of the condition.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
On March 11, Pharmac’s clinical lead of medicines management Melissa Copland confirmed funding from April 1.
Endometriosis: Tauranga woman welcomes Pharmac’s decision to fund CerazetteThe New Zealand Herald – country’s largest newspaper, est. 1863·
New Zealand· 2025-03-16
New Zealand· 2025-03-16
On March 11, Pharmac’s clinical lead of medicines management Melissa Copland confirmed funding from April 1.
Endometriosis: Tauranga woman welcomes Pharmac’s decision to fund CerazetteThe New Zealand Herald – country’s largest newspaper, est. 1863·New Zealand· 2025-03-16
New Zealand· 2025-03-16